
Experimental treatment borrowed from blood cancer shows promise for pediatric brain tumors
CAR-T has been used to treat certain blood cancers for two decades and got its first Food and Drug Administration approval in 2017. In recent years, doctors have been exploring the treatment in solid tumors, including those in the brain, where patients …